by Baylor College of Medicine Graphical abstract. Credit: Journal of Clinical Investigation (2023). DOI: 10.1172/JCI172503 Improving treatments for triple-negative breast cancer (TNBC), an aggressive tumor with very poor prognosis and limited therapeutic targets, has been challenging. Responding to this need for better treatments, researchers at Baylor College of Medicine and collaborating institutions have investigated potential vulnerabilities...
